Literature DB >> 34280016

Antimicrobial Resistance Mechanisms, Multilocus Sequence Typing, and NG-STAR Sequence Types of Diverse Neisseria gonorrhoeae Isolates in KwaZulu-Natal, South Africa.

Nireshni Mitchev1, Ravesh Singh1,2, Mushal Allam3, Stanford Kwenda3, Arshad Ismail3, Nigel Garrett4,5, Veron Ramsuran1, Abraham J Niehaus1, Koleka P Mlisana1,4,6.   

Abstract

Antimicrobial resistance (AMR) is a major challenge to managing infectious diseases. Africa has the highest incidence of gonorrhoea, but there is a lack of comprehensive data from sparse surveillance programs. This study investigated the molecular epidemiology and AMR profiles of Neisseria gonorrhoeae isolates in KwaZulu-Natal province (KZN), South Africa. Repository isolates from patients attending public health care clinics for sexually transmitted infection (STI) care were used for phenotypic and genotypic analysis. An Etest was performed to determine antimicrobial susceptibility. Whole-genome sequencing (WGS) was used to determine epidemiology and to predict susceptibility by detecting resistance-associated genes and mutations. Among the 61 isolates, multiple sequence types were identified. Six isolates were novel, as determined by multilocus sequence typing. N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) determined 48 sequence types, of which 35 isolates had novel antimicrobial profiles. Two novel penA alleles and eight novel mtrR alleles were identified. Point mutations were detected in gyrA, parC, mtrR, penA, ponA, and porB1. This study revealed a high prevalence of AMR (penicillin 67%, tetracycline 89%, and ciprofloxacin 52%). However, spectinomycin, cefixime, ceftriaxone, and azithromycin remained 100% effective. This study is one of the first to comprehensively describe the epidemiology and AMR of N. gonorrhoeae in KZN, South Africa and Africa, using WGS. KZN has a wide strain diversity and most of these sequence types have been detected in multiple countries; however, more than half of our isolates have novel antimicrobial profiles. Continued surveillance is crucial to monitor the emergence of resistance to cefixime, ceftriaxone, and azithromycin.

Entities:  

Keywords:  AMR; gonorrhoea; sexually transmitted diseases

Mesh:

Substances:

Year:  2021        PMID: 34280016      PMCID: PMC8448096          DOI: 10.1128/AAC.00759-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area.

Authors:  Iona M C Martin; Catherine A Ison; David M Aanensen; Kevin A Fenton; Brian G Spratt
Journal:  J Infect Dis       Date:  2004-03-31       Impact factor: 5.226

2.  Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.

Authors:  Walter Demczuk; Irene Martin; Pam Sawatzky; Vanessa Allen; Brigitte Lefebvre; Linda Hoang; Prenilla Naidu; Jessica Minion; Paul VanCaeseele; David Haldane; David W Eyre; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

4.  Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar.

Authors:  Chun-Hsing Liao; Chih-Cheng Lai; Meng-Shuian Hsu; Fang-Yeh Chu; Mei-Yu Wu; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2010-02-25       Impact factor: 5.283

5.  Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa.

Authors:  Liteboho D Maduna; Marleen M Kock; Brian M J W van der Veer; Oscar Radebe; James McIntyre; Lieke B van Alphen; Remco P H Peters
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

6.  A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch.

Authors:  Leonor Sánchez-Busó; Corin A Yeats; Benjamin Taylor; Richard J Goater; Anthony Underwood; Khalil Abudahab; Silvia Argimón; Kevin C Ma; Tatum D Mortimer; Daniel Golparian; Michelle J Cole; Yonatan H Grad; Irene Martin; Brian H Raphael; William M Shafer; Katy Town; Teodora Wi; Simon R Harris; Magnus Unemo; David M Aanensen
Journal:  Genome Med       Date:  2021-04-19       Impact factor: 11.117

Review 7.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.

Authors:  Lori Newman; Jane Rowley; Stephen Vander Hoorn; Nalinka Saman Wijesooriya; Magnus Unemo; Nicola Low; Gretchen Stevens; Sami Gottlieb; James Kiarie; Marleen Temmerman
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

8.  Genomic analyses of Neisseria gonorrhoeae reveal an association of the gonococcal genetic island with antimicrobial resistance.

Authors:  Odile B Harrison; Marianne Clemence; Joseph P Dillard; Christoph M Tang; David Trees; Yonatan H Grad; Martin C J Maiden
Journal:  J Infect       Date:  2016-08-26       Impact factor: 6.072

9.  Genomic epidemiology and population structure of Neisseria gonorrhoeae in Norway, 2016-2017.

Authors:  Kristian Alfsnes; Vegard Eldholm; Anne Olaug Olsen; Ola Brønstad Brynildsrud; Jon Bohlin; Martin Steinbakk; Dominique A Caugant
Journal:  Microb Genom       Date:  2020-03-19

10.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.

Authors:  Jane Rowley; Stephen Vander Hoorn; Eline Korenromp; Nicola Low; Magnus Unemo; Laith J Abu-Raddad; R Matthew Chico; Alex Smolak; Lori Newman; Sami Gottlieb; Soe Soe Thwin; Nathalie Broutet; Melanie M Taylor
Journal:  Bull World Health Organ       Date:  2019-06-06       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.